Log In
Print
BCIQ
Print
Print this Print this
 

ZPL-5212372 (formerly PF-5212372, PLA-950)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionTopical phospholipase A2 group IVA cytosolic calcium-dependent (PLA2G4A) inhibitor
Molecular Target Phospholipase A2 group IVA cytosolic calcium-dependent (PLA2G4A) (cPLA2-alpha)
Mechanism of ActionPhospholipase A2 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today